Zoetis Revenue 2012-2026 | ZTS

Zoetis annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Zoetis revenue for the quarter ending March 31, 2026 was $2.262B, a 1.89% increase year-over-year.
  • Zoetis revenue for the twelve months ending March 31, 2026 was $9.509B, a 2.4% increase year-over-year.
  • Zoetis annual revenue for 2025 was $9.467B, a 2.28% increase from 2024.
  • Zoetis annual revenue for 2024 was $9.256B, a 8.33% increase from 2023.
  • Zoetis annual revenue for 2023 was $8.544B, a 5.74% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Zoetis Annual Revenue
(Millions of US $)
2025 $9,467
2024 $9,256
2023 $8,544
2022 $8,080
2021 $7,776
2020 $6,675
2019 $6,260
2018 $5,825
2017 $5,307
2016 $4,888
2015 $4,765
2014 $4,785
2013 $4,561
2012 $4,336
2011 $4,233
Zoetis Quarterly Revenue
(Millions of US $)
2026-03-31 $2,262
2025-12-31 $2,387
2025-09-30 $2,400
2025-06-30 $2,460
2025-03-31 $2,220
2024-12-31 $2,317
2024-09-30 $2,388
2024-06-30 $2,361
2024-03-31 $2,190
2023-12-31 $2,213
2023-09-30 $2,151
2023-06-30 $2,180
2023-03-31 $2,000
2022-12-31 $2,040
2022-09-30 $2,002
2022-06-30 $2,052
2022-03-31 $1,986
2021-12-31 $1,967
2021-09-30 $1,990
2021-06-30 $1,948
2021-03-31 $1,871
2020-12-31 $1,807
2020-09-30 $1,786
2020-06-30 $1,548
2020-03-31 $1,534
2019-12-31 $1,674
2019-09-30 $1,584
2019-06-30 $1,547
2019-03-31 $1,455
2018-12-31 $1,564
2018-09-30 $1,480
2018-06-30 $1,415
2018-03-31 $1,366
2017-12-31 $1,460
2017-09-30 $1,347
2017-06-30 $1,269
2017-03-31 $1,231
2016-12-31 $1,277
2016-09-30 $1,241
2016-06-30 $1,208
2016-03-31 $1,162
2015-12-31 $1,274
2015-09-30 $1,214
2015-06-30 $1,175
2015-03-31 $1,102
2014-12-31 $1,320
2014-09-30 $1,210
2014-06-30 $1,158
2014-03-31 $1,097
2013-12-31 $1,254
2013-09-30 $1,103
2013-06-30 $1,114
2013-03-31 $1,090
2012-12-31 $1,176
2012-09-30 $1,019
2012-06-30 $1,094
2012-03-31 $1,047
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $49.577B $9.467B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00